Jun 5, 2026 07:00AM
Jun 5, 2026 07:00AM
May 12, 2026 07:00AM
May 5, 2026 07:00AM
May 4, 2026 07:00AM
May 4, 2026 07:00AM
Apr 20, 2026 07:00AM Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
Apr 9, 2026 07:00AM
Mar 12, 2026 07:00AM
Mar 2, 2026 04:06PM
Mar 2, 2026 04:05PM
Feb 12, 2026 07:01AM
Feb 12, 2026 07:00AM
Jan 6, 2026 07:02AM Seres Therapeutics publishes research on VOWST mechanism in medical journals
Jan 6, 2026 07:00AM
Nov 24, 2025 07:00AM
Nov 5, 2025 07:00AM
Oct 30, 2025 07:00AM
Oct 29, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplan
Sep 24, 2025 06:28AM
Sep 23, 2025 07:00AM
Sep 23, 2025 07:00AM
Aug 27, 2025 07:00AM
Aug 6, 2025 07:00AM
Jul 22, 2025 07:07AM
Jul 22, 2025 07:01AM Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
Jul 22, 2025 07:00AM
May 27, 2025 07:02AM
May 27, 2025 07:00AM
May 8, 2025 05:06AM
May 7, 2025 07:00AM
Apr 29, 2025 07:00AM
Apr 23, 2025 07:00AM Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025
Mar 13, 2025 07:00AM
Mar 4, 2025 07:00AM
Mar 3, 2025 07:00AM
Mar 3, 2025 07:00AM
Jan 16, 2025 07:01AM
Jan 16, 2025 07:00AM
Jan 9, 2025 07:00AM Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates
Dec 16, 2024 07:00AM
Dec 9, 2024 07:06AM
Dec 9, 2024 07:00AM
Nov 22, 2024 07:00AM
Nov 13, 2024 07:00AM
Nov 6, 2024 07:00AM
Sep 30, 2024 05:15PM Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A
Sep 26, 2024 04:01PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All